Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...
The University of California Berkeley and UC San Francisco announced this week the launch of the Laboratory for Genomics Research, in which scientists from both institutions will use CRISPR gene ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Künzel, Associate Director in the Functional Genomics department at AstraZeneca, about the application of arrayed ...
Dublin, Ireland, and Cheshire, UK, 04 September 2024: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Medicines Discovery Catapult (‘MDC’), an independent, not-for-profit drug ...
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
Outcomes validate the company’s PTAP platform as a foundation for a rapid, adaptable antiviral modality across animal and ...
New partnership network combines the power of automated CRISPR cell line engineering with phenotypic, functional and multi-omic assays to optimize research workflows. Synthego launches CRISPR ...
Barchart on MSN
This Leading Gene-Editing Stock Could Be Going Private. Should You Buy Its Shares First?
The global cell therapy market was valued at $5.88 billion in 2024 and is on track to hit $44.39 billion by 2034, expanding at a striking 22.69% CAGR. Researchers credit this explosive growth to ...
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback